群发资讯网

返回主页
sulfasalazine
柳氮磺吡啶
常用释义
英音[ ˌsʌlfəˈsæləziːn ]
美音[ ˌsʌlfəˈsæləzɪn ]
基本释义
  • n. 柳氮磺胺吡啶
例句
  • 1·Nonsteroidal anti-inflammatory drugs and sulfasalazine were the mainstay of treatment.
    非甾体抗炎药和柳氮磺吡啶是基本治疗药物。
  • 2·Agents such as sulfasalazine, corticosteroids, azathioprine, TNFa antagonists and thalidomide should be tried first before surgery, except in emergencies.
    在进行手术前(除急诊外),应尝试使用药物如柳氮磺吡啶、激素、硫唑嘌呤、肿瘤坏死因子拮抗剂及反应停。
  • 3·Sulfasalazine possesses both antiinflammatory and antibacterial properties and was mainly used to treat inflammatory bowel disease and rheumatoid arthritis.
    柳氮磺胺吡啶具有消炎和抗菌的性质,主要用于治疗溃疡性结肠炎和类风湿关节炎。
  • 4·Methotrexate plus sulfasalazine is recommended in patients with all disease durations provided they have high disease activity and poor prognostic features.
    甲氨喋呤加柳氮磺吡啶疗法是推荐给那些患病时间长久,病情高度活动、但是没有不良预后特征的患者。
  • 5·The researchers found that people who took TwHF extract had greater improvement in their pain, swelling, and other symptoms than those who took sulfasalazine.
    研究人员发现,服用雷公藤提取物的患者与服用硫氮磺胺吡啶的患者相比较,其疼痛、肿胀及其它症状有更明显的好转。
  • 6·After six months, 65 percent of those taking TwHF extract had at least a 20 percent improvement in their symptoms, compared with 33 percent of those taking sulfasalazine.
    六个月后,服用雷公藤的患者中有65%的人症状至少有20%的好转,而服用硫氮磺胺吡啶的患者中只有33%的患者症状有所好转。
  • 7·Sulfasalazine monotherapy is recommended for patients with all disease durations and without poor prognostic features and includes those with all degrees of disease activity.
    柳氮磺吡啶单一疗法为那些长期患有各种疾病和没有不良预后特征的,包含那些不同严重程度患病的患者推荐。
  • 8·Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
    羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 - 24个月),病情重但是没有不良预后特征的患者。
  • 9·METHODS: 165cases of ulcerative colitis were divided into two groups: trial group (compound glycyrrhizin) and control group (sulfasalazine). The clinical effects were compared between two groups.
    方法:165例溃疡性结肠炎患者随机分为治疗组和对照组,分别给予复方甘草酸苷和柳氮磺胺吡啶治疗,比较两组的临床疗效。